With relationships between manufacturers and physicians under increasing scrutiny, pharma and device compliance staff  need to be able to demonstrate results. They must be able to show that their efforts are actually resulting in interactions with physicians that are compliant and ethical. NAI Consultant, Stephen Rothenberg, J.D., describes how an effective field-based monitoring plan can meet this need, without compromising commercial objectives in his article, Compliance and Field-Based Monitoring, published in Pharmaceutical Compliance Monitor, November 12, 2012.